BlueOcean NutraSciences Announces First Commercial Purchase Order for Bulk Omega-3/Astaxanthin Shrimp Oil

TORONTO, ONTARIO--(Marketwired - Dec. 22, 2015) - BlueOcean NutraSciences (TSX VENTURE:BOC) ("BlueOcean" or the "Company"), a nutraceutical Company focused on developing specialty oils and extended release (XR) Omega-3 and Astaxanthin tablets from shrimp, fish, krill and algae oil for Health and Wellness markets, is pleased to announce that yesterday it received its first commercial purchase order for bulk Northern AstaShrimpTM oil, bulk Pacific AstaShrimpTM oil and newly added bulk Pacific Plus AstaShrimpTM oil, from a Canadian nutraceutical company. The order terms include delivery on or before March 31, 2016 for each product and is cancellable for 30 days.

This is BlueOcean's first bulk shrimp oil order since the Company began assessing commercial potential in March 2013 to produce high value omega-3 and astaxanthin shrimp oil from the shells of Marine Stewardship Council (MSC) certified shrimp sourced from Newfoundland based shrimp processors and shrimp shells sourced from South Pacific Ocean shrimp fisheries. With the various AstaShrimpTM product specifications and commercial extraction capacity finalized earlier this year, customers such as the current one and additional customers that BlueOcean has been working with for the past two years are anticipated to begin placing orders for the 2016 North Atlantic shrimp season and the remainder of the current South Pacific shrimp season.

BlueOcean has now commenced sales of both bulk shrimp oil, as well as its own retail brand of omega-3 shrimp oil products called Pure PolarTM Omega-3 Shrimp Oil which are available online at purepolarshrimp.com, Amazon.com and is now also available at InboxFitness.com.

About BlueOcean NutraSciences:

BlueOcean NutraSciences Inc. is a Canadian listed public Company (TSX VENTURE:BOC) that is focused on developing sustainable, specialty nutraceutical oil products targeted at the rapidly growing Natural Astaxanthin, Omega-3 and Algal oil health and wellness markets. BlueOcean's bulk shrimp oils contain high levels of naturally occurring astaxanthin, phospholipids, and omega-3 EPA and DHA. Northern and Pacific AstaShrimp™ bulk oils are targeted at the high value and rapidly growing natural astaxanthin and phospholipid omega-3 markets.

BlueOcean and its JV partner, CMAX technologies, have developed a process to convert shrimp, krill, algae and other fish oils into Extended Release Tablets. BlueOcean owns 50% of the participating and voting rights in 2453969 Ontario Inc., a joint venture with CMAX Technologies that has developed the extended release omega-3/astaxanthin tablets. 2453969 Ontario Inc. also has a 66.7% ownership in Pure Polar Labs Inc., a Nevada company that sells omega-3 and astaxanthin retail products under the brand Pure Polar.

BlueOcean's Pure Polar™ Omega-3 Shrimp Oil formulations contain over two times more omega-3 EPA & DHA and 10 times more astaxanthin than typical retail krill oil brands, and contain phospholipids for better absorption of omega-3s.
Product details and ordering can be found at: www.purepolarshrimp.com and other fine e-retailers.

Forward Looking Statements: BlueOcean

This news release may contain forward-looking statements that are based on BlueOcean's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.